PHAR
Pharming Group
$12.26
+$0.39 (+3.29%)Oct 28, 2026
Key metrics
The numbers that frame PHAR today
- Market cap
- $867.74M
- P/E (TTM)
- 33.4
- EV / FCF
- 20.4
- Gross margin
- 85.1%
- EV / Sales
- 1.8
- ROIC
- 14.8%
- Div yield
- 0%
- Debt / equity
- 0.4
- 52wk Low
- $9.11
- 52wk High
- $21.34
Growth
Revenue and earnings trend for PHAR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PHAR
Is Pharming Group a good buy?
Yes. Pharming Group has excellent quality, and it outweighs the poor momentum here. Growth looks excellent, which supports the long-term business case. We think Pharming Group is selling at a low price.
What is the market capitalization of PHAR?
Pharming Group's market capitalization is $867.74M.
What is the P/E (TTM) ratio for PHAR stock?
Pharming Group's P/E (TTM) ratio is 33.4, based on trailing earnings.
What is the 52-week high for PHAR stock?
The 52-week high for Pharming Group is $21.34. The current close of $12.26 is 42.5% below that high.
What is the 52-week low for PHAR stock?
The 52-week low for Pharming Group is $9.11. The current close of $12.26 is 34.6% above that low.
Does PHAR stock pay dividends?
Pharming Group does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PHAR?
Pharming Group's Debt / Equity ratio is 0.39.